Overview: The Cancer Genomics Consortium (CGC), formerly the Cancer Cytogenomics Microarray Consortium (CCMC), is a not-for-profit organization formed in 2009 by a group of clinical cytogeneticists, molecular pathologists, and molecular geneticists interested in applying microarray technologies to cancer diagnosis and cancer research. The mission of the consortium is to promote communication and collaboration among cancer cytogenomics laboratories. CGC goals are to: establish platform-neutral and cancer specific microarray designs for diagnostic purposes; share cancer microarray data between participating institutions for education purposes; create a public cancer array database; and carry out multicenter cancer genome translational research.
Current Status: Active
Last Updated: August 5, 2015